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To evaluate protection against Haemonchus contortus, four groups of 10 young goats each 
were vaccinated with the H. contortus gut membrane proteins H11/H-gal-GP either in 4-
week- (V4) or 6-week-intervals (V6, V6SEP). A control group (CTRL) remained 
unvaccinated. After the second vaccination in May all goats were turned out on pastures 
which had been previously contaminated with H. contortus eggs by seeder sheep for six 
weeks. Group V6SEP was grazed separately at an identical stocking rate. Clinical, 
parasitological and serological (vaccine antibodies) parameters were measured fortnightly. All 
goats were stabled in October, drenched with levamisole and two weeks later orally infected 
with 5000 L3 of H. contortus. Four weeks later they were slaughtered to quantify abomasal 
worm burdens. Significantly (p < 0.01) lower faecal egg counts were observed in group 
V6SEP compared with the controls. Mean egg output of all groups fluctuated at low levels 
during the second part of the grazing period. Goats responded to vaccination with increasing 
antibody titres peaking after every booster. Mean worm burdens after experimental infections 
were reduced significantly (p < 0.01) in group V4 compared with the controls. It was 
concluded that the vaccination protocol did not result in sufficient protection against H. 
contortus on pasture, as antibody titres were still low at the time the goats were exposed to 
elevated larval contamination on pasture after turnout. 
Keywords: Goats, Haemonchus contortus, Vaccination, Field study 
 
Zusammenfassung 
Vier Gruppen à 10 Jungziegen wurden mit den Darmmembranproteinen H11/H-gal-GP von 
Haemonchus contortus entweder im 4-Wochen- (V4) oder 6-Wochen-Abstand (V6, V6SEP) 
geimpft, um den Schutz gegen H. contortus zu evaluieren. Eine Kontrollgruppe blieb 
ungeimpft (CTRL). Nach der zweiten Impfung im Mai wurden alle Ziegen auf Weiden 
verbracht, die vorab von Schafen während 6 Wochen mit H. contortus-Eiern kontaminiert 
wurden. Die Gruppe V6SEP weidete separat bei gleicher Besatzdichte. Alle 14 Tage wurden 
klinische, parasitologische und serologische (Vakzine-AK) Parameter gemessen. Im Oktober 
wurden alle Ziegen eingestallt, mit Levamisol entwurmt und zwei Wochen später mit 5000 L3 
von H. contortus oral infiziert. Nach vier Wochen wurden sie geschlachtet und die 
abomasalen Wurmbürden ermittelt. Verglichen zu der Kontrollgruppe waren die Eizahlen im 
Kot in der Gruppe V6SEP signifikant (p < 0.01) reduziert. Während der Weideperiode 
fluktuierten die durchschnittlichen Eizahlen im Kot aller Gruppen auf tiefem Niveau. Die 
Ziegen reagierten mit steigenden AK-Titern, die nach jedem Booster einen Peak ergaben. 
Nach der Kontrollinfektion waren die abomasalen Wurmbürden in Gruppe V4 verglichen mit 
denen der Gruppe CTRL signifikant (p < 0.01) reduziert. Die Ergebnisse weisen darauf hin, 
dass die Impfprotokolle nicht in einem ausreichenden Schutz der Ziegen gegenüber H. 
contortus resultierten, da die AK-Titer zur Bewältigung des bereits bei Weideaustrieb 
bestehenden erhöhten Infektionsdrucks noch zu niedrig waren. 
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Haemonchus contortus Control 
Vaccination Field 
study 
Forty goats, aged from 2 to 5 months were subjected to two different immunization protocols with  a 
vaccine containing Haemonchus contortus gut membrane proteins H11/H-gal-GP to evaluate protection 
against H. contortus on pre-contaminated pastures. Goats were allocated to four groups of ten, three of 
them received their first vaccination before turnout. One group (V4) was then vaccinated at  4-week- 
intervals whereas another two groups (V6 and V6SEP) were vaccinated at 6-week-intervals. A control 
group (CTRL) remained unvaccinated. In May, after the second vaccination, all goats were turned out on 
pastures which had been previously contaminated with H. contortus eggs by seeder sheep for a period of 
six weeks. Goats of groups V4, V6 and CTRL were grazed together, whereas V6SEP was kept separately at an 
identical stocking rate. Clinical (PCV, FAMACHA, body weight), parasitological (faecal egg count, FEC) and 
serological (antibody titres) parameters were measured fortnightly. All goats were stabled in October, 
drenched with levamisole and two weeks later infected with 5000 L3 of H. contortus and slaughtered 
four weeks later for determination of abomasal worm burdens. Group mean FEC peaked 42–56 days 
after turnout. Significantly lower FEC were observed in V6SEP vs CTRL between D 28 and 70 (p < 0.01). 
Mean egg output of all groups decreased substantially and fluctuated at low levels until the end of the 
grazing period (D 154). Goats responded to vaccination with increasing antibody titres peaking after 
every booster. Mean worm burdens deriving from experimental infections were reduced by 89, 65 and 
47% in groups V4, V6 and V6SEP, respectively, compared with the controls. The difference was significant 
for V4 (p < 0.01). Antibody titres measured 14 days before slaughter did not correlate statistically with 
the worm burdens. It was concluded that the vaccination protocol did not result in sufficient protection 
on pasture, as antibody titres were still low at the time the goats were exposed to larval contamination 
on pasture after turnout. 





Amongst gastrointestinal nematodes (GIN), Haemonchus contor- tus is 
one of the most economically important parasites in goats and sheep 
worldwide (Zajac, 2006). The clinical and economic losses are mainly 
associated with the consequences of blood-sucking activ- ity of 
the preadult and adult stages. Current control strategies against 
GIN usually rely on repeated anthelmintic treatments. As a 
consequence, anthelmintic resistance in ovine and caprine GIN is 
widespread (Saddiqi et al., 2011; Papadopoulos et al., 2012). Var- 
ious alternative strategies for GIN-control have been investigated, 
including nematophagous fungi, bioactive forage crops and breed- 
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ing for genetic resistance (reviewed by Waller (2006)). Specific 
immunization is currently the most advanced approach for non- 
chemical control of H. contortus. Most studies have been carried 
out in sheep based on gut membrane proteins of adult H. contor- 
tus (Kabagambe et al., 2000; LeJambre et al., 2008), or recombinant 
vaccines (Cachat et al., 2010). Very few trials focused on vaccination 
of goats, all of them with somatic (Ruiz et al., 2004; Molina et al., 
2012) or recombinant antigens (Han et al., 2012). The use of native 
hidden antigens based on the H11 and H-gal-GP complex has so 
far resulted in the highest protection in sheep (reviewed by Smith 
and Zarlenga (2006)). At present no published report is available 
on the use of native H11 and H-gal-GP complex in goats. Therefore a 
grazing experiment was performed with young goats to investi- 
gate different immunization regimes based on the H11/H-gal-GP 
antigen complex under the conditions of the Swiss midland region. 
 
http://dx.doi.org/10.1016/j.vetpar.2016.08.024 0304-
4017/© 2016 Elsevier B.V. All rights reserved. 
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The experiment was performed with 40 castrated male Chamoix 
goats purchased from a local farm. The goats had been reared 
indoors and were fed hay and commercial pelleted rations after 
being weaned at the age of 8–10 weeks. They had free access to 
fresh water and mineralized salt. After arrival at the study site at 
April 2 (D-36) they were two to five months old, with an average 
of 106 days. Prior to the first samplings, the goats were adapted 
for one week to the new environment. During 4 weeks of adapta- 
tion to pasture-feeding (D-28 to 0), the goats were fed hay, weaned 
from pelleted food, and diet was continuously changed from hay 
to grass. One week after arrival, the majority of goats developed 
pneumonia and were treated twice within 14 days with 10 mg/kg 
body weight (BW) tilmicosin (Micotil® 300, Provet AG Switzerland) 
and 0.5 mg/kg BW meloxicam (Metacam® 20 mg, Boehringer Ingel- 
heim GmbH Switzerland). After having been base-immunized in 
the breeding stable, at D 28 all goats were boostered against 
Clostridium perfringens infection (Ovilis® Heptavac P, Veterinaria 
AG Switzerland), followed by a further immunization at the end of 
August. 
The animal experiments were carried out in accordance with 





The trial was conducted at the experimental farm of the Federal 
Institute of Technology of Zurich in the canton of Zug, Switzerland 
(47◦ 10I 34.99II N, 8◦ 25I 35.02II E; 444 m.a.s.l.) from April to 
November 2012. The experimental pastures had not been grazed by 
farm animals during the previous year. Before the goats were trans- 
ferred, the experimental pastures had been contaminated for six 
weeks by four adult seeder sheep, each of which had been infected 
with 3000 third stage larvae (L3) of a local H. contortus isolate. These 
sheep exhibited FEC between 2440 and 5040 during the seeding 
period. 
 
1.3. Experimental design 
 
At arrival the goats were ranked according to body weight, 
blocked and randomly assigned to four groups (V4, V6, CTRL, V6SEP) 
of 10 animals each (group average 19.9 kg). At the same occasion the 
goats were treated anthelmintically to eliminate potential infec- 
tions with GIN. Anthelmintic treatment consisted of a combination 
of levamisole hydrochloride and triclabendazole (Endex® 8.75%, 
Novartis AG Switzerland), administered orally at a single dosage of 
12 and 16 mg/kg BW, respectively. Levamisole was chosen as it was 
known to be fully effective against the selected H. contortus-isolate. 
In Switzerland, levamisole is only marketed as a combination with 
triclabendazole. 
Absence of strongylid eggs in faeces was investigated by fae- cal 
egg counts and coprocultures. Goats were vaccinated with 5 µg of 
H. contortus gut membrane proteins in 1 ml QuilA adjuvant 
subcutaneously, a vaccine recently commercialized as Barbervax® 
(barbervax.com.au) in Australia. Prior to use, the vaccine was stored 
at 4 ◦C. Goats of groups V4, V6, V6SEP received a basic immuniza- 
tion before turnout at D-28 and 0. After turnout boosters were 
applied either every 4 (V4) or 6 weeks (V6 and V6SEP) for a total   of 
8 (V4) and 6 (V6, V6SEP) immunizations, respectively. Goats of 
CTRL-group remained unvaccinated. A packed cell volume (PCV) 
with values of less than 20% or a faecal egg count (FEC) of higher 
than 1000 eggs per gram (epg) were chosen as a threshold for 
administering  a  salvage treatment. 
At May 8 (D 0) the animals were turned out on two adjacent pas- 
tures, designed for an average stocking rate of 125 square meters per 
goat. Groups V4, V6 and CTRL were grazed together on one pasture 
(P1), group V6SEP grazed separately (P2). The size of the paddocks 
was increased stepwise over the season, according to the availability 
of grass. The goats stayed on pasture permanently until October 9 (D 
154) and were only brought into the stable for sam- plings and 
during one period of 4 days at the end of August, when the 
temperature during daytime exceeded 30 ◦C and goats were kept 
indoors during the day. Goats were only fed grass, except dur- ing 
the last 6 weeks at the end of the trial when they were fed     hay 
indoors. In August, restricted to a period of two and a half weeks 
after they had started to lose weight, all goats were supple- mented 
daily with 1 kg hay and 400 g commercial pelleted rations (UFA 763, 
UFA AG, Switzerland). For the last phase of the trial, at  D 154 all 
animals were treated with levamisole/triclabendazole at   a dose rate 
as described above and housed until slaughter (on D 196/197). 
Herewith the different vaccination protocols could be re- evaluated 
after the goats had experienced the same conditions of 
housing/infection-pressure. So at D 168, the animals of the three 
vaccinated groups received a final vaccination dose, and all goats 
were challenged orally with 5000 third-stage-larvae of the same H. 





All goats were sampled fortnightly from D -28 until D 168, then 
sampling was undertaken weekly until slaughter. At the sampling 
days, the general condition of each goat was clinically examined by a 
veterinarian, which included weighing with an electronic scale 
(accuracy 0.1 kg), and scoring for the degree of anemia (1–5) by 
examining the eye mucosa using the FAMACHA card (van Wyk 
and Bath, 2002). Individual faecal samples were collected directly 
from the rectum, and blood samples were collected from the jugu- 
lar vein into sterile blank 9 ml Vacuette tubes and 2 ml Vacuette 
tubes containing EDTA, respectively. Despite all goats being boost- 
ered against C. perfringens infection, one goat died 3 days after the 
injection (D -25) because of peracute infection with C. perfringens 
Type D. Another goat died by asphyxiation 3 days after turnout as 
a consequence of a fencing accident during night. Data from those 
2 goats were discarded from the calculations. 
 
 
1.5. Parasitological  techniques 
 
FEC were performed using a modified McMaster method with a 
sensitivity of 50 epg (Schmidt, 1971). Eggs other than strongyles 
were categorized separately. For identification of infective larvae, 
coprocultures were made according to Eckert (1960). Pooled fae- 
cal samples of each treatment group were mixed with sawdust 
and incubated for 7 days at 27 ◦C. From each culture, 100 third- 
stage-larvae (L3) were morphologically differentiated according 
to the guidelines of MAFF (Ministry of Agriculture, 1986). Pas- 
ture contamination with infective larvae was determined according 
to Sievers Prekehr (1973), modified by Hertzberg et al. (1996). 
Every 6–8 weeks, the presence of lungworm larvae and liver fluke 
eggs was tested with the Baermann and sedimentation technique, 
respectively. After slaughter and exsanguination, the abomasa 
were ligated and removed immediately. The contents were washed 
thoroughly and filtered through a 200 µm sieve. A 10% aliquot was 
separated and fixed with formaline at a final concentration of 4%. 
Male and female adults and juveniles of H. contortus were counted 
under a dissecting microscope at a magnification of 50 and the total 




1.6. Packed cell volume and serology 
 
Packed cell volume (PCV) was measured within 4 h after blood 
sampling using a microcentrifuge. Serum was separated by cen- 
trifugation and stored at 20 ◦C until the end of the experiment. 
Antibody titres were determined by ELISA. Briefly, Microlon 96W 
microtitre plates (Greiner Labs, Scotland) were coated with 50 µl    of 
a 1 µg/ml H11/H-gal-GP solution in sodium carbonate buffer (50 
mM carbonate, pH 9.6) overnight at 4 ◦C. After washing the Plates 6 
times with PBS, the wells were blocked with 10% (w/v) Infasoy 
(Cow and Gate Ltd.) in TNTT (10 mM Tris-HCl, 0.5 M NaCl, 0.05% 
v/v Tween 20, 0.01% w/v thimerosal, pH 7.4), incubated for 2 h at 
room temperature (RT) and washed again. Serum samples from each 
goat were diluted 1: 100 in TNTT, and from that a series of doubling 
dilutions were made from 1: 200–1: 204I800 and 50 µl  of each 
dilution was added in the wells and incubated at RT for 1 h. After 6 
washes, 50 µl mouse monoclonal anti-goat/sheep IgG-horse radish 
peroxidase (HRPO) conjugate (Sigma Cat#A9452) was added to each 
well, diluted 1: 10I000 in TNTT, and incubated 1 h at RT. Following 6 
washings 50 µl o-phenylenediaminedihydrochloride (OPD) substrate 
(Sigma) was added to each well. After 20 min of incubation at RT in 
the dark, the reaction was stopped by adding  25 µl of 2.5 M sulfuric 
acid to each well and the absorbance read at 490 nm with an ELISA 
plate reader. Individual titres of each goat are expressed as that 
dilution of the serum required to give the same absorbance as the 
negative control serum diluted 1:    200. 
 
1.7. Statistical methods 
 
All analysis was undertaken in R (R-Core-Team, 2015).Variation in 
PCVs were analysed using a linear mixed effect model. Vari- 
ation in egg counts were examined using a negative binomial 
linear mixed effect model. AD Model builder software (Fournier 
et al., 2012) implemented in R via the glmmADMB package (Skaug 
et al., 2014) was used to estimate parameters of the mixed effects 
models. The MASS (Venables and Ripley, 2002) package was used 
for parameter estimation of fixed effects models. Vaccination and 
anthelmintic treatment were taken as fixed effects with animal as a 
random effect. Group means of body weight gain during the grazing 
season were compared with a t-test using IBM SPSS Statistics 21. A 
linear mixed model on log + 1 transformed data was used to com- 
pare antibody titres over the season, with goat as the random effect 
and date and vaccination protocol as a fixed effect. Association of 
total antibody titres at D 28 with the egg counts of D 42 was deter- 
mined by using negative binomial regression model fixed effects 
model. A negative binomial model was used to compare total worm 
counts and the Fisher test was used to compare the percentage of 
female worms. 
 
1.8. Meteorological  data 
 
Data on precipitation and air temperature were obtained from the 
national weather service. The next meteorological station was 
situated at an aerial distance of 5 km to the experimental farm. Total 
daily precipitation and mean daily temperature (24 h, 2 m above 




2.1. Faecal egg counts and larval   differentiation 
 
The pattern of H. contortus FEC in all groups was characterized by a 
sharp increase in June (Fig. 1). At D 56 mean egg counts from 
groups V4, CTRL and V6SEP peaked at 4300, 4200 and 1250 epg, 
respectively. Mean egg excretion from group V6 reached a maxi- 
mum of 2950 epg at D 42. The peaks in the faecal egg counts were 
followed by a rapid decline in July and low levels from August 
onwards. After levamisole treatment at the end of the grazing period 
(D 154) egg counts turned to zero. Goats from V6SEP shed the fewest 
eggs during the whole trial with an overall mean of 206 epg 
comparing to overall means of 401 (V4), 504 (V6) and 539 (CTRL) 
with only the difference between V6SEP and CTRL being significant 
(p < 0.05). Following larval challenge at D 168, FEC reached mean 
values of 5, 50, 210 and 33 at slaughter (D 196/197) in groups V4, V6, 
CTRL and V6SEP, respectively. The overall low levels did not allow 
statistical comparison during this phase. Coprocultures   confirmed 
H. contortus being the only trichostrongylid nematode appearing 
during the whole trial. Eggs of Nematodirus battus, Trichuris ovis 
and Strongyloides papillosus were rarely found in faecal samples of 
all groups at low levels. 
 
 
2.2. Worm burden 
 
Mean worm burdens of all vaccinated groups were lower com- 
pared with CTRL with reductions of 88.5%, 65.4% and 46.5% in 
groups V4, V6 and V6SEP, respectively (Fig. 2). This difference was 
significant in group V4 (p < 0.01). In all groups fewer female than 
male worms were recovered. With a rate of female worms of 27 and 
31% this difference was significant in groups V4 and V6, compared 
with 42% in the CTRL group (p < 0.05). 
 
 
2.3. Packed cell volume and FAMACHA-scores 
 
Mean PCV values ranged between 29.5 and 31.4 at turnout (Fig. 
3). Values began to decrease in all groups by D 28. Declin- ing 
values were observed until D 98 reaching mean levels around 20, 
and afterwards PCV increased constantly, up to over 30 until 
slaughter. Differences were not significant between the groups (p 
> 0.05). Mean overall PCV values during the grazing season were 
25.4, 24.5, 24.7 and 26.2 for V4, V6, CTRL and V6SEP, respectively. 
FAMACHA scores started with values around 3.3 at turnout (Fig. 
3). Values fluctuated similarly in the three vaccinated groups 
around values of 3.5 until D 98, and decreased to values near 3 (V4, 
V6) or below 3 (V6SEP) until the end of the grazing period. Overall, 
the highest values, indicating palest mucosa, were seen in CTRL. 
Mean FAMACHA scores were lowest for V6SEP (3.1), followed by 
V4 and V6 (both 3.3) and CTRL (3.6). FAMACHA scores 4 and 5 sig- 
nificantly correlated with the PCV (p < 0.005), but not scores 2 and 





All vaccinated groups exhibited antibody titres of 7700–9700 after 
the third immunization (Fig. 4). Subsequently each anti- gen 
application stimulated an antibody response reaching highest 
mean titres after the 6th (V4: 24I504) or 5th (V6: 13I033, V6SEP: 
14I099) vaccination. The linear mixed model indicated substan- 
tially higher titres for the vaccination groups compared to the 
controls through the grazing season (V4, p < 0.00001, V6 p < 0.002, 
V6SEP p < 0.0005). Mean antibody titres of V6 and V6SEP followed a 
similar course during the trial. Titres of V4 fluctuated at higher 
levels compared with the other groups. Mean titres of the CTRL 
group increased constantly throughout the grazing period, reach- 
ing a maximum of 6I376 at D 154 and decreased immediately after 
anthelmintic treatment. Individual antibody titres from D 28 
compared with FEC from D 42 revealed no significant correlation 
(p > 0.05). Furthermore no correlation between antibody titres from 





Fig. 1. Mean faecal egg counts in four groups of goats. Group V4 was vaccinated in 4-week and groups V6 and V6SEP in 6-week intervals, V6SEP goats grazed a separate 
pasture. Group CTRL remained unvaccinated. The hashtag (#) is indicating the experimental infection of all goats with 5000 third stage larvae (L3) of H. contortus at day 168. 
 
 
Fig. 2. Mean adult male and female H. contortus counts in four groups of goats after slaughter. Group V4 was vaccinated in 4-week and groups V6 and V6SEP in 6-week 
intervals, V6SEP goats grazed a separate pasture. Group CTRL remained unvaccinated. 
 
2.5. Body weight, clinical condition and anthelmintic treatments 
 
Mean group BW at turnout (D 0) ranged between 23.8–24.6 kg. 
During the grazing period (D 0-154), a significant higher mean daily 
weight gain (p < 0.05) was observed in groups V6 (60 g) and V6SEP 
(73 g) compared to CTRL (41 g), which represents a difference of 
+47% (V6) and +79% (V6SEP). The benefit of group V4 (+53 g) was 
not significant (p > 0.05). 
Clinical signs of haemonchosis were not observed during the 
whole experiment. In total, eighteen individual anthelmintic treat- 
ments were administered according to the preset conditions. The 
number of treatments was 4, 7, 1 and 6 in groups V4, V6, V6SEP and 
CTRL, respectively. In group V6 two goats and in group CTRL one 
goat had to be treated twice. 
 
 
2.6. Pasture larval counts 
 
Contamination of both pastures with H. contortus-larvae devel- 
oped fairly similar over the whole grazing season (Fig. 5). Larval 
contamination increased to 2100 L3/kg dry matter (DM) on P1 
(grazed by V4, V6, CTRL) and 1900 L3/kg DM on P2 (V6SEP) from 
days 42–56, and gradually decreased during August and September 




Mean 24 h temperatures during May ranged from 10 to 21 ◦C 
(monthly average 14.9 ◦C). June, July and August were warmer with 
mean 24h-temperatures between 13–25 ◦C (monthly average 18.3, 
18.7, 20.1, respectively). Compared to the long year average, May, 
June and July were about 2 ◦C warmer, the other months ranged 
close to the averages. 
Rainfall occurred periodically throughout the entire grazing period. 
Monthly values ranged close to the long-year average except in May 




The aim of the study was to compare different vaccination 
protocols based on H. contortus intestinal membrane glycopro- 
teins (H11/H-gal-GP complex) in their ability to induce protection 





Fig. 3. Mean PCV (open symbols) and FAMACHA scores (filled symbols) in four groups of goats. Group V4 was vaccinated in 4-week and groups V6 and V6SEP in 6-week 
intervals, V6SEP goats grazed a separate pasture. Group CTRL remained unvaccinated. The hashtag (#) is indicating the experimental infection of all goats with 5000 third 
stage larvae (L3) of H. contortus at day 168. 
 
 
Fig. 4. Mean antibody titres against H11/H-gal-GP in four groups of goats. Group V4 was vaccinated in 4-week and groups V6 and V6SEP in 6-week intervals, V6SEP goats 
grazed a separate pasture. Group CTRL remained unvaccinated. The hashtag (#) is indicating the experimental infection of all goats with 5000 third stage larvae (L3) of H. 
contortus at day 168. 
 
contaminated pastures. None of the chosen strategies was able to 
protect goats sufficiently as indicated by a similar development of 
FEC, PCV and FAMACHA. Unlike other vaccination trials per- 
formed with sheep (Andrews et al., 1997; Kabagambe et al., 2000; 
LeJambre et al., 2008), goat antibody titres increased slower after 
the first and second injection to values around 2000–3000. There- 
fore titres were still too low for inducing protection after turnout 
on contaminated pastures, which was supported by the lack of cor- 
relation of antibody titres at D 28 with the FEC two weeks later. 
To aquire protection against enterotoxaemia (Clostridium perfrin- 
gens type D) goats need to build up higher antibody levels (Uzal 
et al., 1998) compared with sheep (Oxer et al., 1971). The reason 
for this apparently different pattern in goats and sheep is unclear, 
but together with the observation that antibody levels in young 
goats are of short duration (Uzal et al., 1998), these findings may 
indicate why in the present study the vaccination protocol derived 
from sheep was not equally successful in goats. As even with much 
higher antibody titres (around 60,000), protection is not complete 
(Bassetto et al., 2014). To our knowledge published reports about 
the use of native concealed antigens against H. contortus-infection 
in goats are not available to date. In comparable studies with sheep, 
titres of approximately 6000, (measured with the same technol- 
ogy) were induced four weeks after first vaccination, when animals 
were successfully facing larval challenge (LeJambre et al., 2008). The 
observation that after the third immunization of group V4 at mid- 
June, despite titres close to 10I000, there was still an increase of 
mean FECs two weeks later, suggests that in goats even higher titers 
may be necessary to induce sufficient protection; much higher than 
in sheep. 
The vaccination protocol is clearly reflected by the zigzag- shaped 
development of the antibody-peaks of the vaccinated groups. This 
pattern is typically induced by the QuilA adjuvant used in this 
experiment, which is known to induce only short-termed 






Fig. 5. H. contortus third stage larval counts on two pastures grazed either by three experimental groups (V4, V6, CTRL, Pasture 1) or one group (V6SEP, Pasture 2). 
 
these conditions repeated injections are mandatory as the antibody 
response against the concealed antigens can only be marginally 
boostered by natural challenge (Knox et al., 2003). However, unvac- 
cinated animals of the control group were able to generate antibody 
responses against the gut antigens, indicated by steadily increasing 
titers throughout the grazing period and immediate decline after 
deworming. This is supporting earlier suggestions that H11/H-gal- 
GP may not be completely hidden for the immune system (Smith 
et al., 2001). Alternatively, unknown homologous epitopes out- 
side the gut may simultaneously stimulate the antibody response 
(LeJambre et al., 2008). The initial peak in FEC in June/July was 
directly followed by an increase of the pasture contamination with 
infective larvae. While egg counts in naïve goats under continuous 
challenge with H. contortus usually remain at high levels for a longer 
period (Miller et al., 2011), the mean egg output of vaccinated and 
control goats of the present study dropped to very low levels by D 
84. Most likely, the sudden increase of pasture contamination with 
infective larvae measured at the beginning of July has induced a 
self-cure reaction (Luffau et al., 1981; Adams, 1983), removing the 
majority of the existing infection within a very short period. There- 
fore, the specific role of vaccination could not be assessed after this 
event. Furthermore, the reason for the apparent lack of re-infection 
after the self-cure reaction remains unclear. Larval contamination, 
arising from the egg-contamination from mid-June to mid-July per- 
sisted approximately until the beginning of September. During this 
period sufficient pressure for reinfection should have been present. 
However, the very low egg output during August to September in 
all groups except V6 showed that all groups, including CTRL were 
able to successfully manage the larval challenge on pasture. The 
intention of running the V6SEP-group on a separate pasture was to 
determine the epidemiological benefit of vaccination under condi- 
tions where unvaccinated animals are excluded. Unfortunately, due 
to the low egg excretion in all groups during the second part of the 
grazing season, the consequences of a reduced larval contamina- 
tion on the V6SEP-pasture could not be assessed. However, despite 
a substantially lower number of necessary treatments in the V6SEP- 
group, these goats exhibited a significantly higher weight gain, 
suggesting an epidemiological benefit for vaccinating the entire 
group. 
Worm burdens deriving from experimental infection at the end of 
the trial were significantly lower in group V4 compared with CTRL 
and the percent of female worms was significantly reduced in 
groups V4 and V6 compared to CTRL, most likely indicating 
the higher blood intake of the female worms (Smith and Smith, 
1993). Although the mean antibody titres of V4 measured 14 days 
before necropsy reflected the higher intensity of vaccination in this 
group, no correlation was found between the individual titres and 
the worm burden at necropsy. This might have been caused i) by 
the limited group size or ii) by the relatively low mean worm bur- 
den in all groups, which most likely reflects an additional immune 
protection induced by H. contortus-infection. 
Under farming conditions in Switzerland and bordering coun- 
tries adult goats are responsible for initial contamination of the 
pastures with H. contortus-eggs in spring, mimicked by the seeder 
sheep in the present study. For indoor-born kids a sufficient time 
period should be made available for a set of three vaccinations in 
3-week intervals, which, according to the present results, will 
most likely be necessary to protect the offspring against larval chal- 
lenge after turnout. A more difficult situation is arising for kids 
born close to or even after turnout. Here, assuming an age of 4 
weeks for the first vaccination, kids would be aged approximately 
11 weeks before immune protection has developed sufficiently, 
which in most cases will be too late to avoid a scenario experienced 
in the present study. 
The results document the challenge to synchronize vaccina- tion 
against H. contortus with the farm management. For achieving 
similar results as in sheep (LeJambre et al., 2008), additional 
studies are needed to develop a vaccination protocol able to suf- 
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